Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma

NCT01691807

Conditions
Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Southaven, Mississippi, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site San Antonio, Texas, United States
View Trial Details
Completed

Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma

NCT01534078

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hosptial Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma

NCT02247869

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • UO Ematologia Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy
  • Dipartimento di Oncologia Medica ed Ematologia Istituto Clinico Humanitas Rozzano, Milano, Italy
  • Oncologia HSR Giglio Cefalù, Palermo, Italy
  • Oncologia Medica A Centro di Riferimento Oncologico Aviano, Pordenone, Italy
View all 37 locations
View Trial Details
Completed

BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in R/R HL Patients Non Responding to IGEV

NCT02244021

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
Locations
  • Istituto di Ematologia "L. & A. Seragnoli" , Policlinico S. Orsola Malpighi Bologna, Italy
  • Ematologia, IRCCS AOU San Martino-IST Genova, Italy
  • Ematologia Ospedale Vito Fazzi Lecce, Italy
  • Ematologia e Unità BMT IRCCS Istituto Nazionale dei Tumori Milan, Italy
View Trial Details
Completed

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

NCT00784537

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • Centro di riferimento Oncologico Oncologia Medica A Aviano, Italy
  • Università Policlinico di Bari - Divisione di Medicina A Bari, Italy
  • Policlinco Sant'Orsola Isituto di Ematologia ed oncologia Medica Bologna, Italy
  • Sezione di Ematologia Spedali Civili Brescia, Italy
View all 27 locations
View Trial Details
Completed

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

NCT01805375

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +22 more
Locations
  • Royal Liverpool and Broadgreen University Hospital NHS Trust Liverpool, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • The Churchill Hospital Oxford, United Kingdom
  • Derriford Hospital Plymouth, United Kingdom
View Trial Details

Related conditions